← Browse by Condition
Medical Condition
soft tissue sarcoma
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1, Phase 2
ClinicalMetric tracks all active clinical trials for soft tissue sarcoma sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — soft tissue sarcoma Clinical Trials
How many clinical trials are currently recruiting for soft tissue sarcoma?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for soft tissue sarcoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for soft tissue sarcoma?
soft tissue sarcoma research spans Phase 1 (1 trial), Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a soft tissue sarcoma clinical trial?
Eligibility criteria for soft tissue sarcoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Phase 2 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT03175718
Recruiting
INPWT on Wound Complications & Clinical Outcomes After Lower Extremity Sarcoma Surgery Preop Radiation Therapy Patients
Enrollment
291 pts
Location
Canada
Sponsor
Dr. J. Werier
NCT06943521 Phase 1, Phase 2
Recruiting
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Enrollment
27 pts
Location
United States, Japan
Sponsor
Tanabe Pharma America, Inc.
NCT06436846
Recruiting
Genomic Risk in Retroperitoneal Sarcoma
Enrollment
50 pts
Location
United States
Sponsor
Fox Chase Cancer Center
NCT06129903
Recruiting
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
Enrollment
60 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology